|4Sep 14, 8:35 PM ET

SCO CAPITAL PARTNERS LLC 4

4 · ABEONA THERAPEUTICS INC. · Filed Sep 14, 2020

Insider Transaction Report

Form 4
Period: 2020-09-10
Transactions
  • Sale

    Common Stock

    2020-09-11$2.01/sh4,600$9,24411,921,281 total(indirect: By LLC)
  • Sale

    Common Stock

    2020-09-10$2.08/sh73,411$152,48211,925,881 total(indirect: By LLC)
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.01 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
  • [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020.

Documents

1 file
  • 4
    ownership.xmlPrimary